These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
629 related items for PubMed ID: 18645111
21. Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States. Russo MW, Galanko J, Beavers K, Fried MW, Shrestha R. Liver Transpl; 2004 Mar; 10(3):340-6. PubMed ID: 15004758 [Abstract] [Full Text] [Related]
22. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus. Taner CB, Bulatao IG, Keaveny AP, Willingham DL, Pungpapong S, Perry DK, Rosser BG, Harnois DM, Aranda-Michel J, Nguyen JH. Liver Transpl; 2011 Jun; 17(6):641-9. PubMed ID: 21618684 [Abstract] [Full Text] [Related]
23. Liver transplantation using donors older than 80 years: a single-center experience. Petridis I, Gruttadauria S, Nadalin S, Viganò J, di Francesco F, Pietrosi G, Fili' D, Montalbano M, D'Antoni A, Volpes R, Arcadipane A, Vizzini G, Gridelli B. Transplant Proc; 2008 Jun; 40(6):1976-8. PubMed ID: 18675105 [Abstract] [Full Text] [Related]
24. Liver transplantation from old donors into HCV and non-HCV recipients. Baccarani U, Adani GL, Toniutto P, Sainz M, Lorenzin D, Viale PL, Ramacciato G, Risaliti A, Bresadola F. Transplant Proc; 2004 Apr; 36(3):527-8. PubMed ID: 15110581 [Abstract] [Full Text] [Related]
25. The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C. Yagci G, Fernandez LA, Knechtle SJ, D'Alessandro AM, Chin LT, Musat AI, Lucey MR, Said A, Pirsch JD, Leverson G, Kalayoglu M. Transplant Proc; 2008 Apr; 40(1):219-23. PubMed ID: 18261591 [Abstract] [Full Text] [Related]
26. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Berenguer M, Prieto M, San Juan F, Rayón JM, Martinez F, Carrasco D, Moya A, Orbis F, Mir J, Berenguer J. Hepatology; 2002 Jul; 36(1):202-10. PubMed ID: 12085366 [Abstract] [Full Text] [Related]
27. Donor pool expansion in liver transplantation. Montalti R, Nardo B, Bertelli R, Beltempo P, Puviani L, Vivarelli M, Cavallari A. Transplant Proc; 2004 Apr; 36(3):520-2. PubMed ID: 15110578 [Abstract] [Full Text] [Related]
28. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up. Neumann UP, Berg T, Bahra M, Puhl G, Guckelberger O, Langrehr JM, Neuhaus P. Transplantation; 2004 Jan 27; 77(2):226-31. PubMed ID: 14742986 [Abstract] [Full Text] [Related]
29. Liver transplantation for HCV-associated liver cirrhosis: predictors of outcomes in a population with significant genotype 3 and 4 distribution. Zekry A, Whiting P, Crawford DH, Angus PW, Jeffrey GP, Padbury RT, Gane EJ, McCaughan GW, Australian and New Zealand Liver Transplant Clinical Study Group. Liver Transpl; 2003 Apr 27; 9(4):339-47. PubMed ID: 12682883 [Abstract] [Full Text] [Related]
30. Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation. Saab S, Chang AJ, Comulada S, Geevarghese SK, Anselmo RD, Durazo F, Han S, Farmer DG, Yersiz H, Goldstein LI, Ghobrial RM, Busuttil RW. Liver Transpl; 2003 Oct 27; 9(10):1053-61. PubMed ID: 14526400 [Abstract] [Full Text] [Related]
31. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Machicao VI, Bonatti H, Krishna M, Aqel BA, Lukens FJ, Nguyen JH, Rosser BG, Satyanarayana R, Grewal HP, Hewitt WR, Harnois DM, Crook JE, Steers JL, Dickson RC. Transplantation; 2004 Jan 15; 77(1):84-92. PubMed ID: 14724440 [Abstract] [Full Text] [Related]
32. Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients. Maluf DG, Edwards EB, Stravitz RT, Kauffman HM. Liver Transpl; 2009 Jun 15; 15(6):592-9. PubMed ID: 19479802 [Abstract] [Full Text] [Related]
33. Elderly donors for HCV(+) versus non-HCV recipients: patient survival following liver transplantation. Boin IF, Ataide EC, Leonardi MI, Stucchi R, Sevá-Pereira T, Pereira IW, Cardoso AR, Caruy CA, Luzo A, Leonardi LS. Transplant Proc; 2008 Apr 15; 40(3):792-6. PubMed ID: 18455019 [Abstract] [Full Text] [Related]
34. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients. Burra P, Loreno M, Russo FP, Germani G, Galligioni A, Senzolo M, Cillo U, Zanus G, Fagiuoli S, Rugge M. Liver Transpl; 2009 Jun 15; 15(6):619-28. PubMed ID: 19479805 [Abstract] [Full Text] [Related]
35. Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survival. Ghabril M, Dickson RC, Machicao VI, Aranda-Michel J, Keaveny A, Rosser B, Bonatti H, Krishna M, Yataco M, Satyanarayana R, Harnois D, Hewitt W, Willingham DD, Grewal H, Hughes CB, Nguyen J. Liver Transpl; 2007 Dec 15; 13(12):1717-27. PubMed ID: 18044750 [Abstract] [Full Text] [Related]
37. Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression. Toniutto P, Minisini R, Fabris C, De Feo T, Marangoni F, Burlone M, Avellini C, Bitetto D, Fornasiere E, Fumolo E, Baccarani U, Pirisi M. Clin Transplant; 2009 Aug 15; 23(2):184-90. PubMed ID: 19210526 [Abstract] [Full Text] [Related]
38. Survival outcome after hepatic retransplantation for hepatitis C virus-positive and -negative recipients. Jain A, Orloff M, Abt P, Kashyap R, Mohanka R, Lansing K, Romano J, Bozorgzadeh A. Transplant Proc; 2005 Sep 15; 37(7):3159-61. PubMed ID: 16213336 [Abstract] [Full Text] [Related]
39. Contribution of marginal donors to liver transplantation for hepatitis C virus infection. Briceño J, Ciria R, Pleguezuelo M, Naranjo A, Sánchez-Hidalgo J, Ruiz-Rabelo J, López-Cillero P, Luque A, de la Mata M, Rufián S. Transplant Proc; 2007 Sep 15; 39(7):2297-9. PubMed ID: 17889169 [Abstract] [Full Text] [Related]